Clinical Trial Update: Assessing the Effects of Ongoing Ocrelizumab (OCR) Therapy on Fatigue and Cognition in Veterans With Multiple Sclerosis [NA]

View source ↗

Summary

This clinical trial update describes ongoing ocrelizumab therapy in veterans with multiple sclerosis to assess its effects on fatigue and cognition; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: Anza Memon | Conditions: Multiple Sclerosis | NA | Status: NOT_YET_RECRUITING